Get research updatesBipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.
A Multicenter, Randomized, Double Blind, Placebo-controlled, Parallel Group, Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Treatment of Major Depressive Episode Associated With Bipolar I or II Disorder
Current recruitment status is unconfirmed.
In SeoulA Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Aripiprazole in the Treatment of Patients With Bipolar I Disorder With a Major Depressive Episode. CN138-146 LT is the 26-week Open Label Extension Phase of the Above Titled Protocol, CN138-146 ST.
This study has finished and is no longer accepting participants.
Multiple locations, including MesaResearchers compared JNJ-55308942 and placebo to find out how the approaches affected depression symptoms in people with bipolarity during a depressive episode.
This study has finished and is no longer accepting participants.
Multiple locations, including HuntsvilleEvaluation of the Effect of Carbamazepine on the Steady-state Pharmacokinetics of Paliperidone Extended Release in Clinically Stable Subjects With Schizophrenia or Bipolar I Disorder
This study has finished and is no longer accepting participants.
Location not clearly listedPhase II/III Study of FK949E: Placebo-controlled, Double-blind, Parallel-group Comparative Study and Open-label, Non-controlled Extension Study in Bipolar Disorder Patients With Major Depressive Episodes
This study has finished and is no longer accepting participants.
Multiple locations, including AichiA Sequential Groups, Open Label, Rising Multiple Dose Study to Assess the Pharmacokinetics, Safety and Tolerability of Sublingual Asenapine in a Pediatric Population With Schizophrenia or Bipolar I Disorder
This study has finished and is no longer accepting participants.
Location not clearly listedA Multiple Dose Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ABBV-932 in Healthy Adult Subjects, Subjects With Generalized Anxiety Disorder (GAD) and Subjects With Bipolar Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including Los AlamitosResearchers compared Topiramate and placebo to find out how the approaches affected manic symptoms in young people with bipolarity type I.
This study has finished and is no longer accepting participants.
Location not clearly listedA Phase 1b, Open-label, Multiple-dose, Randomized, Parallel-arm, Safety, Tolerability, and Pharmacokinetic Trial of Aripiprazole Intramuscular Depot Administered in the Gluteal Muscle in Adult Subjects With Schizophrenia or Bipolar I Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockAn Open-label, Single- and Multiple-dose, Pharmacokinetic, Safety, and Tolerability Trial of Aripiprazole Long-acting Injectable Administered in the Deltoid or Gluteal Muscle in Adult Subjects With Schizophrenia or Bipolar I Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockA Randomized Controlled Trial of the Fatty Acid Amide Hydrolase Inhibitor Palmitoylethanolamide in Bipolar Depression
This study has finished and is no longer accepting participants.
In Houston
Adjunctive Acupuncture as a Treatment for Bipolar Depression
This study has finished and is no longer accepting participants.
In DallasWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.